Review



protein lysate  (Jena Bioscience)


Bioz Verified Symbol Jena Bioscience is a verified supplier
Bioz Manufacturer Symbol Jena Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Jena Bioscience protein lysate
    Protein Lysate, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cy5%2E5-Azide/pmc13096800-47-10-3
    Average 94 stars, based on 11 article reviews
    protein lysate - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Isolation of proteins on chromatin (iPOC) reveals signaling pathway-dependent alterations in the DNA-bound proteome.
    Article Snippet: min. Cells were then spun down for 5 min at 900g and washed once with cold 0.5% BSA in 1x PBS, and once in 1x PBS. Permeabilized cells were then resuspend in click reaction buffer (10 μM biotin azide (Jena Bioscience CLK-047), 10 mM sodium ascorbate, 2 mM CuSO4 in PBS 1%) at RT, in the dark for 2h. Cells were then spun down for 5 min at 900g, washed once with cold 0.5% BSA in PBS, and once with 1x

    Lysis:

    Article Title: Isolation of proteins on chromatin (iPOC) reveals signaling pathway-dependent alterations in the DNA-bound proteome.
    Article Snippet: min. Cells were then spun down for 5 min at 900g and washed once with cold 0.5% BSA in 1x PBS, and once in 1x PBS. Permeabilized cells were then resuspend in click reaction buffer (10 μM biotin azide (Jena Bioscience CLK-047), 10 mM sodium ascorbate, 2 mM CuSO4 in PBS 1%) at RT, in the dark for 2h. Cells were then spun down for 5 min at 900g, washed once with cold 0.5% BSA in PBS, and once with 1x



    Similar Products

    sulfo cy5 azide  (Lumiprobe)
    96
    Lumiprobe sulfo cy5 azide
    Sulfo Cy5 Azide, supplied by Lumiprobe, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Sulfo-Cyanine5+azide/bio_rxiv__64898__2026__10__06__757210-244-7-8
    Average 96 stars, based on 1 article reviews
    sulfo cy5 azide - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    cy5 azide lumiprobe a3030 ascorbic acid sigma a4544 propidium iodide sigma p4864 dapi sigma d9542 hydroxyurea hu  (Lumiprobe)
    97
    Lumiprobe cy5 azide lumiprobe a3030 ascorbic acid sigma a4544 propidium iodide sigma p4864 dapi sigma d9542 hydroxyurea hu
    Cy5 Azide Lumiprobe A3030 Ascorbic Acid Sigma A4544 Propidium Iodide Sigma P4864 Dapi Sigma D9542 Hydroxyurea Hu, supplied by Lumiprobe, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cyanine5+azide/pm42859192-274-202-204
    Average 97 stars, based on 1 article reviews
    cy5 azide lumiprobe a3030 ascorbic acid sigma a4544 propidium iodide sigma p4864 dapi sigma d9542 hydroxyurea hu - by Bioz Stars, 2026-11
    97/100 stars
    		  Buy from Supplier
    cy5 5 azide  (Lumiprobe)
    93
    Lumiprobe cy5 5 azide
    Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with <t>Cy5.5,</t> and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.
    Cy5 5 Azide, supplied by Lumiprobe, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cyanine5%2E5+azide/pmc13624526-71-2-6
    Average 93 stars, based on 1 article reviews
    cy5 5 azide - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    protein lysate  (Jena Bioscience)
    94
    Jena Bioscience protein lysate
    Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with <t>Cy5.5,</t> and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.
    Protein Lysate, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cy5%2E5-Azide/pmc13096800-47-10-3
    Average 94 stars, based on 1 article reviews
    protein lysate - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    fluorescent dye cy5 5 azide  (Jena Bioscience)
    94
    Jena Bioscience fluorescent dye cy5 5 azide
    Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with <t>Cy5.5,</t> and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.
    Fluorescent Dye Cy5 5 Azide, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cy5%2E5-Azide/pmc13096800-47-0-3
    Average 94 stars, based on 1 article reviews
    fluorescent dye cy5 5 azide - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    cy5 5 azide  (Jena Bioscience)
    94
    Jena Bioscience cy5 5 azide
    Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with <t>Cy5.5,</t> and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.
    Cy5 5 Azide, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cy5%2E5-Azide/pmc13096800-47-17-3
    Average 94 stars, based on 1 article reviews
    cy5 5 azide - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    fluorescent dye cy5 5azide  (Jena Bioscience)
    94
    Jena Bioscience fluorescent dye cy5 5azide
    Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with <t>Cy5.5,</t> and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.
    Fluorescent Dye Cy5 5azide, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cy5-azide/Cy5%2E5-Azide/pm42011781-49-0-3
    Average 94 stars, based on 1 article reviews
    fluorescent dye cy5 5azide - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with Cy5.5, and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: Targeting Microglial HDAC5 Suppresses NLRP3 Inflammation via NF ‐ κB Deacetylation to Alleviate Ischemic Brain Injury

    doi: 10.1002/cns.71161

    Figure Lengend Snippet: Preparation and characterization of RGD‐EV:MiR‐9‐5p. (A) Western blot was used to detect the expression of the positive markers Alix and TSG101 in EVs. (B) Representative images of TTC‐stained brains from I/R model mice at 24 h after tail vein injection of PBS or EVs. (C) Quantification of infarct volume after TTC staining, n = 3. (D) Neurological deficit scores in the sham group, and I/R model mice treated with EVs or PBS. (E) RT‐PCR analysis of the levels of 10 different miRNAs in HEK293T‐derived EVs and ReN‐derived EVs ( n = 3). (F) After EV ReN was added to HT‐22 cells for 24 h, OGD experiments were performed and 5 miRNAs were detected ( n = 3). *denotes comparison with the Control group, *** p < 0.001; # denotes comparison between the OGD group and the OGD + EV ReN group, ### p < 0.001. (G) The binding sites of miR‐9‐5p on Hdac5 were predicted by TargetScan. (H) Dual‐luciferase reporter gene assay was used to verify the binding between miR‐9‐5p and Hdac5 . (I) BV2 cells were transfected with miR‐9‐5p mimics, and after 48 h, the expression of HDAC5 in the cells was analyzed by Western blot. (J) Quantification of HDAC5 ( n = 4). (K) Schematic of RGD‐EV, labeled with Cy5.5, and loaded with cholesterol‐modified miR‐9‐5p. (L, M) TEM imaging (L) and NTA (M) of RGD‐EV: MiR‐9‐5p; scale bar 200 nm. (N, O) MCAO/R mice were injected with Cy5.5‐labeled RGD‐EVs or RGD‐EV: MiR‐9‐5p, and Cy5.5 levels in the brain were analyzed 24 h later. Representative brain NIR fluorescence images (N) and quantification of intracerebral fluorescence intensity (O) are shown, n = 3. (P) After ischemia modeling in mice, tdTomato‐labeled EVs were injected into the tail vein and perfused 24 h later. Fluorescent staining was performed to analyze whether EVs had entered into microglia in the ischemic region; red indicates EVs, green indicates microglia, and the scale bar is 25 μm. (Q, R) BV2 cells were pretreated with PBS, EV (or EV: MiR‐NC, or EV: MiR‐9‐5p) for 24 h before LPS treatment. The expression of HDAC5 (Q) in the cells were determined by Western blot analysis, and quantification of HDAC5 (R), n = 3. Data are expressed as mean ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one‐way ANOVA.

    Article Snippet: For imaging, Cy5.5 azide (0.3 nmol; Lumiprobe, USA) was added simultaneously.

    Techniques: Western Blot, Expressing, Staining, Injection, Reverse Transcription Polymerase Chain Reaction, Analysis, Derivative Assay, Comparison, Control, Binding Assay, Luciferase, Reporter Gene Assay, Transfection, Labeling, Modification, Imaging, Fluorescence